The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients.

Huibo WangZhenfeng HuangBingqi XuJinxing ZhangPengfei HeFei GaoRuifeng ZhangXiatian HuangMing Shan

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)

Both pre- and post-treatment systemic immune-inflammatory markers have a significant predictive role in achieving pCR after NAT in breast cancer patients. Indeed, it is possible that post-treatment markers have stronger predictive ability compared to pre-treatment markers.

Keyphrases

patients undergoing
ejection fraction
lymph node
end stage renal disease
rectal cancer
radiation therapy
young adults
peritoneal dialysis
smoking cessation